SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-22-004445
Filing Date
2022-06-16
Accepted
2022-06-16 12:48:57
Documents
63
Period of Report
2022-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q thct_10q.htm   iXBRL 10-Q 969419
2 CERTIFICATION thct_ex311.htm EX-31.1 8913
3 CERTIFICATION thct_ex312.htm EX-31.2 8675
4 CERTIFICATION thct_ex321.htm EX-32.1 3046
5 CERTIFICATION thct_ex322.htm EX-32.2 3399
  Complete submission text file 0001477932-22-004445.txt   4037938

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA thct-20220430.xsd EX-101.SCH 47641
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE thct-20220430_lab.xml EX-101.LAB 227868
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thct-20220430_cal.xml EX-101.CAL 41132
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thct-20220430_pre.xml EX-101.PRE 194273
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thct-20220430_def.xml EX-101.DEF 115528
57 EXTRACTED XBRL INSTANCE DOCUMENT thct_10q_htm.xml XML 593561
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 833-420-8428
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

IRS No.: 260164981 | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55994 | Film No.: 221019936
SIC: 3523 Farm Machinery & Equipment